{
    "organizations": [],
    "uuid": "8e4e3ec74da0cbc8dcb8fca7b21bc281920e9314",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ironwood-and-allergan-announce-set/brief-ironwood-and-allergan-announce-settlement-with-aurobindo-pharma-resolving-linzess-patent-litigation-idUSFWN1SA1AE",
    "ord_in_thread": 0,
    "title": "Ironwood And Allergan Announce Settlement With Aurobindo Pharma Resolving Linzess Patent Litigation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Allergan plc:\n* IRONWOOD AND ALLERGAN ANNOUNCE SETTLEMENT WITH AUROBINDO PHARMA RESOLVING LINZESS (LINACLOTIDE) PATENT LITIGATION\n* SETTLEMENT WITH AUROBINDO IS SECOND PATENT INFRINGEMENT SETTLEMENT COMPANIES HAVE REACHED WITH RESPECT TO LINZESS\n* IRONWOOD, CO TO GRANT AUROBINDO PHARMA LICENSE TO MARKET GENERIC VERSION OF LINZESS IN UNITED STATES BEGINNING ON AUG 5, 2030\n* ALL ONGOING HATCH-WAXMAN LITIGATION BETWEEN COMPANIES AND AUROBINDO PHARMA REGARDING LINZESS PATENTS WILL BE DISMISSED\n* ADDITIONAL DETAILS REGARDING SETTLEMENT WERE NOT DISCLOSED Source text for Eikon:\nOur ",
    "published": "2018-05-04T04:22:00.000+03:00",
    "crawled": "2018-05-04T16:59:50.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "allergan",
        "plc",
        "ironwood",
        "allergan",
        "announce",
        "settlement",
        "aurobindo",
        "pharma",
        "resolving",
        "linzess",
        "linaclotide",
        "patent",
        "litigation",
        "settlement",
        "aurobindo",
        "second",
        "patent",
        "infringement",
        "settlement",
        "company",
        "reached",
        "respect",
        "linzess",
        "ironwood",
        "co",
        "grant",
        "aurobindo",
        "pharma",
        "license",
        "market",
        "generic",
        "version",
        "linzess",
        "united",
        "state",
        "beginning",
        "aug",
        "ongoing",
        "litigation",
        "company",
        "aurobindo",
        "pharma",
        "regarding",
        "linzess",
        "patent",
        "dismissed",
        "additional",
        "detail",
        "regarding",
        "settlement",
        "disclosed",
        "source",
        "text",
        "eikon"
    ]
}